on 22 Jan 2025
Last Applicant/ Owned by
Tigen Pharma SA
voie du Chariot 3CH-1003 Lausanne
CH
Serial Number
2108227 filed on 4th Feb 2021
Correspondent Address
GOWLING WLG (CANADA) LLP
SUITE 2600, 160 ELGIN STREETOTTAWA
ONTARIO
CA
K1P1C3
Trademark usage description
préparations chimiques, biochimiques, biologiques et biotechnologiques, nommément, polypeptides et protéines pour utilisation en recherche in vitro et Read MoreVienna Information
26 . 1 . 1
CirclesCercles
26 . 1 . 3
One circle or ellipseUn cercle ou une ellipse
27 . 5 . 1
Letters presenting a special form of writingLettres présentant un graphisme spécial
27 . 5 . 7
Letters surmounted by a sign of disproportionate size -- Note: Includes, for instance, a letter i surmounted by a disproportionate dot, by a star or a flower.Lettres surmontées d'un signe de dimension disproportionnée -- Note: Comprend par exemple la lettre i surmontée d'un point disproportionné, d'une étoile ou d'une fleur.
27 . 5 . 19
Letters overlappingLettres se chevauchant
11
11
11
11
11
2108227
Trademark
Action Taken | Status |
---|---|
Submitted for opposition 22 on 16th Jun 2022 | Search Recorded |
Submitted for opposition 20 on 16th Jun 2022 | Examiner's First Report |
Submitted for opposition 223 on 16th Jun 2022 | Total Provisional Refusal |
Submitted for opposition 210 on 9th Jun 2022 | IR Correction |
Submitted for opposition 256 on 21st Mar 2022 | Notification of Possible Opposition Sent |
Submitted for opposition 257 on 20th May 2021 | Designation Notification - Madrid Protocol |
Submitted for opposition 1 on 19th May 2021 | Created |
Submitted for opposition 31 on 19th May 2021 | Formalized |
Submitted for opposition 228 on 4th Feb 2021 | International Registration |
Submitted for opposition 30 on 4th Feb 2021 | Filed |